Intas Pharmaceuticals Limited Fulvestrant Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Fulvestrant Export Records India — #1 Exporter, 160 Shipments, $4.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fulvestrant

India Pharmaceutical Trade Intelligence

$14.6M84 Suppliers66 CountriesHS 30049049

ExportsIndia → UNITED STATES30.0%India → BELGIUM10.2%

ImportsGERMANY → India$949.4K UNITED KINGDOM → India$335.9K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: YUSEN LOGISTICS

Intas Pharmaceuticals Limited — Fulvestrant Exporter #1 | $4.6M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Fulvestrant Exporter Profile

Indian Pharmaceutical Exporter · #1 for Fulvestrant · $4.6M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Fulvestrant with $4.6M in export value and 160 verified shipments. Intas Pharmaceuticals Limited holds a 30.3% market share in Fulvestrant exports across 11 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Fulvestrant Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Fulvestrant export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Fulvestrant?

Country	Value	Shipments	Share
NETHERLANDS	$852.6K	25	26.5%
SPAIN	$563.3K	20	17.5%
BRAZIL	$432.0K	10	13.4%
POLAND	$431.6K	13

Who Are the Top Buyers of Fulvestrant from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
FARMAVENIX	SPAIN	$507.3K	17
ACCORD HEALTHCARE ITALIA SRL	ITALY	$392.1K	8
BROCACEF NL : HUB	NETHERLANDS	$354.7K	14
AMERISOURCE HEALTH SERVICES	UNITED STATES	$245.4K	5
ACCORD HEALTHCARE POLSKA SP. Z O.O.	POLAND	$224.9K	6
BROCACEF NL : DUTCH	NETHERLANDS	$150.0K	3
ACCORD FARMACEUTICA LTDA	BRAZIL	$140.7K	4
ACCORD HEALTHCARE POLSKA SP. Z.O.O.	POLAND	$139.4K	4
BROCACEF NL HUB	NETHERLANDS	$138.7K	3
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$100.0K	2

Intas Pharmaceuticals Limited supplies Fulvestrant to 30 buyers globally. The largest buyer is FARMAVENIX (SPAIN), followed by ACCORD HEALTHCARE ITALIA SRL (ITALY) and BROCACEF NL : HUB (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Fulvestrant Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI FULVESTRANT PFS,250M	$615.1K	18
PHARMA DRUGS & MEDI:ONNIMIA FULVESTRANT	$352.8K	12
PHARMA DRUGS & MEDI: FULVESTRANT PFS,250	$228.9K	23
PHARMA DRUG&MED:FULVESTRANT PFS,250MG/5M	$198.0K	4
PHARMA DRUGS & MEDI:FULVESTRANT PFS,250M	$100.5K	6
PHARMA DRUGS AND MEDI FULVESTRANT INJ.50	$100.0K	2
PHARMA DRUG&MED: FULVESTRANT 250MG/5ML 1	$100.0K	2
PHARMA DRUG&MED: FULVESTRANT 250MG/5ML 1X2PFSAC-BR Each pre filled syringe of5 mL contains: Fulvestrant USP 250 mg Re	$100.0K	2
PHARMA DRUGS & MEDI FULVESTRANT PFS,250MG/5ML,2P(ACO-FRANCE AS PER INVOICENOS	$91.3K	4
PHARMA DRUGS MEDI FULVESTRANT PFS 250MG 5ML 2P ACO NETHERL AS PER INVOICE	$88.3K	2

Intas Pharmaceuticals Limited exports 75 distinct Fulvestrant formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI FULVESTRANT PFS,250M with 18 shipments worth $615.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Fulvestrant Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$4.4M	160	11	$27.7K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$1.1M	22	3	$50.0K
4	DR REDDYS LABORATORIES LIMITED	$650.0K	13	6	$50.0K

Intas Pharmaceuticals Limited ranks #1 among 84 Indian Fulvestrant exporters. Average shipment value of $27.7K compared to the market average of $102.9K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and DR REDDYS LABORATORIES LIMITED.

Which Indian Ports Ship Fulvestrant Exports?

Port	Shipments	% Share
SAHAR AIR	98	20.1%
AHEMDABAD AIR ACC (INAMD4)	71	14.6%
SAHAR AIR CARGO ACC (INBOM4)	56	11.5%
Bombay Air	33	6.8%
MUNDRA SEA (INMUN1)	24	4.9%
AHEMDABAD AIR	24	4.9%
DELHI AIR	21	4.3%
DELHI AIR CARGO ACC (INDEL4)	17	3.5%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Fulvestrant Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fulvestrant shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 167 individual customs records matching Intas Pharmaceuticals Limited exporting Fulvestrant, covering 75 formulations to 12 countries via 30 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 66+ countries, 148+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fulvestrant

Fulvestrant

Intas Pharmaceuticals Limited — Fulvestrant Exporter Profile

Intas Pharmaceuticals Limited — Fulvestrant Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Fulvestrant?

Who Are the Top Buyers of Fulvestrant from Intas Pharmaceuticals Limited?

What Is India's Total Fulvestrant Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Fulvestrant Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Fulvestrant Exporters?

What Fulvestrant Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Fulvestrant to Key Markets

Brazil — ANVISA

How Does Intas Pharmaceuticals Limited Compare to Nearest Fulvestrant Exporters?

Which Indian Ports Ship Fulvestrant Exports?

What Other Advanced Oncology Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Fulvestrant Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fulvestrant Export Data from Intas Pharmaceuticals Limited

Fulvestrant Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source